TEMPOL Enhances Polyethylene Glycol Axon Fusion Following Sciatic Nerve Transection in Adult Rats

Read full text
Authors: Lynn Ana Flavia Salamanca-Guillén, Liana Melo-Thomas, Kelly C. S. Roballo, Vieira, Andre Schwambach, 1982-, Bruno Henrique de Melo Lima, Luciana Politti Cartarozzi, Alexandre Leite Rodrigues de Oliveira
Cited by: 1
References: 99

Abstract

High Resolution Image Download MS PowerPoint Slide Neurotmesis, the most severe form of peripheral nerve injury, involves complete transection and loss of motor and sensory function. Surgical repair, typically via end-to-end neurorrhaphy (NRR), is often required. A key pathological feature is Wallerian degeneration (WD) in the distal stump, which, along with slow axonal regeneration, leads to muscle atrophy and poor functional recovery. Polyethylene glycol (PEG)-mediated axonal fusion has emerged as a promising strategy to bypass WD by rapidly reconnecting severed axons and restoring conduction. Methylene blue (MB) has previously enhanced PEG-fusion outcomes. This study investigated whether TEMPOL (TMP), a potent antioxidant, could further improve PEG-fusion-mediated repair following sciatic nerve transection in rats. Adult female Lewis rats underwent unilateral sciatic nerve transection and were randomly assigned to one of three groups: end-to-end neurorrhaphy (NRR), MB-PEG-fusion (MB-fusion), or TEMPOL-PEG-fusion (TMP-fusion). Functional recovery was assessed for 8 weeks using CatWalk gait analysis (Peroneal Functional Index, PFI). Electrophysiological recordings (CMAPs) were obtained at baseline, immediately post-repair, and at 8 weeks. Histological and immunofluorescence analyses (neurofilament, S100, synaptophysin, GFAP, Iba-1) were performed to evaluate axonal integrity, Schwann cell activity, synaptic coverage, and glial response. TMP-fusion significantly improved motor recovery compared to MB-fusion and NRR. Animals treated with TMP-fusion demonstrated superior sensorimotor function by week 8 (PFI; p = 0.0232, step sequence; p < 0.05), enhanced nerve conduction (CMAPs amplitude, p < 0.05), preserved axonal morphology (NF; p < 0.0001, S100, p = 0.0004), and reduced glial activation (Iba-1, p = 0.0035; GFAP, p = 0.001) compared to NRR. Synaptic integrity in the spinal cord was better maintained in the TMP-fusion group, indicating a more complete restoration of neuromuscular connectivity ( p < 0.0001; p = 0.0003). TEMPOL-PEG-fusion significantly enhances structural and functional recovery after neurotmesis, outperforming current gold-standard techniques. These results support TMP-fusion as a promising strategy for peripheral nerve repair.

Fields of Study & Subjects

Nerve injury and regeneration Nerve Injury and Rehabilitation Botulinum Toxin and Related Neurological Disorders

Publication details

Journal / source
ACS Chemical Neuroscience
Publisher
American Chemical Society (ACS)
Volume
17
Issue
7
Pages
1269–1285
Publication date
27 February 2026
Language
EN